Novel approaches to immunotherapy: epitopes, determinants, activators, or modulators?
Berrens
L
L
C.B.F., LETI, S.A., Tres Cantos, Madrid, Spain.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D003888:Desensitization, Immunologic / Q000379:methods*; D000939:Epitopes / Q000276:immunology / Q000627:therapeutic use; D006801:Humans; D011935:Reagins / Q000276:immunology; D014944:World Health Organization
D000276:Adjuvants, Immunologic; D000939:Epitopes; D011935:Reagins